Pharmacodynamic Biomarkers in Model-Based Drug Development in Oncology

By  

Current Clinical Pharmacology, Vol. 6, Iss. 1, 2011-02 ,pp. : 30-40

Bentham Science Publishers

Access to resources Recommend Favorite

Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity

By Nucci Gianluca   Gomeni Roberto   Poggesi Italo  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 8, 2009-08 ,pp. : 837-856

Informa Healthcare

Access to resources Recommend Favorite

Model‐Based Discovery and Development of Biopharmaceuticals: A Case Study of Mavrilimumab

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 7, Iss. 1, 2018-01 ,pp. : 5-15

John Wiley & Sons Inc

Access to resources Recommend Favorite

Model-based approaches to predict drug–drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyond

By Barton Hugh A   Lai Yurong   Goosen Theunis C   Jones Hannah M   El-Kattan Ayman F   Gosset James R   Lin Jian   Varma Manthena V  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 459-472

Informa Healthcare

Access to resources Recommend Favorite

Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation

By  

Current Drug Metabolism, Vol. 17, Iss. 5, 2016-06 ,pp. : 456-468

Bentham Science Publishers

Access to resources Recommend Favorite